2171

COM:CARSGEN

CARsgen Therapeutics

  • Stock

Last Close

6.71

08/11 08:08

Market Cap

2.36B

Beta: -

Volume Today

85.30M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-265.13M
-
-1.06B
301.33%
-4.74B
345.17%
-890.95M
81.19%
-747.39M
16.11%
depreciation and amortization
19.57M
-
40.11M
104.96%
52.45M
30.76%
81.53M
55.46%
87.39M
7.19%
deferred income tax
39.70M
-
703.43M
1,671.68%
4.15B
490.22%
51.43M
-
stock based compensation
1.93M
-
1.71M
11.05%
13.50M
687.86%
43.99M
225.79%
14.46M
67.14%
change in working capital
27.28M
-
13.45M
50.70%
13.38M
0.54%
43.48M
225.00%
211.38M
386.12%
accounts receivables
-2.33K
-
364
115.63%
-6.54K
1,897.53%
-2.61K
60.13%
inventory
-683K
-
accounts payables
other working capital
27.29M
-
13.45M
50.71%
13.39M
0.48%
43.48M
224.86%
212.06M
387.66%
other non cash items
-2.35M
-
10.20M
533.04%
-6.64M
165.16%
78.89M
1,287.27%
-72.20M
191.52%
net cash provided by operating activities
-179.00M
-
-295.15M
64.88%
-512.32M
73.58%
-643.05M
25.52%
-454.94M
29.25%
investments in property plant and equipment
-103.46M
-
-18.73M
81.89%
-178.45M
852.51%
-138.61M
22.32%
-9.55M
93.11%
acquisitions net
2.32B
-
47.15M
-
purchases of investments
-4.76B
-
-3.48B
26.82%
-2.04B
41.48%
sales maturities of investments
170.14M
-
2.44B
-
5.93B
142.54%
2.04B
65.61%
other investing activites
16.30M
-
11.84M
27.38%
-2.29B
19,468.71%
82.60M
103.60%
1.65M
98.00%
net cash used for investing activites
82.98M
-
-6.90M
108.31%
-2.47B
35,731.83%
2.39B
196.59%
39.25M
98.36%
debt repayment
-244.12M
-
-157.78M
35.37%
-146.87M
6.92%
-327.75M
123.16%
-4.85M
98.52%
common stock issued
2.58B
-
10.51M
99.59%
6.61M
37.08%
common stock repurchased
dividends paid
other financing activites
271.65M
-
1.46B
437.55%
244.81M
83.23%
80.73M
67.02%
-303K
100.38%
net cash used provided by financing activities
27.53M
-
1.30B
4,631.62%
2.67B
105.30%
-236.51M
108.84%
-22.14M
90.64%
effect of forex changes on cash
1.42M
-
-53.93M
3,911.52%
-42.07M
21.99%
69.32M
264.77%
19.54M
71.81%
net change in cash
-67.08M
-
946.49M
1,511.05%
-351.69M
137.16%
1.58B
548.34%
-418.28M
126.53%
cash at beginning of period
163.55M
-
96.48M
41.01%
1.04B
981.07%
691.28M
33.72%
2.27B
228.09%
cash at end of period
96.48M
-
1.04B
981.07%
691.28M
33.72%
2.27B
228.09%
1.85B
18.44%
operating cash flow
-179.00M
-
-295.15M
64.88%
-512.32M
73.58%
-643.05M
25.52%
-454.94M
29.25%
capital expenditure
-103.46M
-
-18.73M
81.89%
-178.45M
852.51%
-138.61M
22.32%
-9.55M
93.11%
free cash flow
-282.46M
-
-313.88M
11.12%
-690.77M
120.07%
-781.66M
13.16%
-464.48M
40.58%

All numbers in (except ratios and percentages)